Fang HB - Search Results

1

Cyclometalated iridium(III) complexes as anti-breast cancer and anti-metastasis agents via STAT3 inhibition.

Su Y, Yang J, Wang MM, Fang HB, Liu HK, Yu ZH, Su Z. Su Y, et al. Among authors: fang hb. J Inorg Biochem. 2024 Feb;251:112427. doi: 10.1016/j.jinorgbio.2023.112427. Epub 2023 Nov 14. J Inorg Biochem. 2024. PMID: 37979498

2

Anticancer copper complex with nucleus, mitochondrion and cyclooxygenase-2 as multiple targets.

Shi X, Fang H, Guo Y, Yuan H, Guo Z, Wang X. Shi X, et al. J Inorg Biochem. 2019 Jan;190:38-44. doi: 10.1016/j.jinorgbio.2018.10.003. Epub 2018 Oct 15. J Inorg Biochem. 2019. PMID: 30352314

3

Photoactivated Lysosomal Escape of a Monofunctional Pt^II Complex Pt-BDPA for Nucleus Access.

Xue X, Qian C, Fang H, Liu HK, Yuan H, Guo Z, Bai Y, He W. Xue X, et al. Angew Chem Int Ed Engl. 2019 Sep 2;58(36):12661-12666. doi: 10.1002/anie.201906203. Epub 2019 Jul 28. Angew Chem Int Ed Engl. 2019. PMID: 31243832 Review.

4

Dual inhibition of oxidative phosphorylation and glycolysis to enhance cancer therapy.

Sheng X, Wang MM, Zhang GD, Su Y, Fang HB, Yu ZH, Su Z. Sheng X, et al. Among authors: fang hb. Bioorg Chem. 2024 Jun;147:107325. doi: 10.1016/j.bioorg.2024.107325. Epub 2024 Apr 2. Bioorg Chem. 2024. PMID: 38583247

5

Iridium(III)-Based PD-L1 Agonist Regulates p62 and ATF3 for Enhanced Cancer Immunotherapy.

Deng D, Wang M, Su Y, Fang H, Chen Y, Su Z. Deng D, et al. J Med Chem. 2024 Apr 25;67(8):6810-6821. doi: 10.1021/acs.jmedchem.4c00404. Epub 2024 Apr 13. J Med Chem. 2024. PMID: 38613772

6

Mitochondria-targeted ruthenium complexes can be generated in vitro and in living cells to target triple-negative breast cancer cells by autophagy inhibition.

Zhang GD, Wang MM, Su Y, Fang H, Xue XL, Liu HK, Su Z. Zhang GD, et al. J Inorg Biochem. 2024 Jul;256:112574. doi: 10.1016/j.jinorgbio.2024.112574. Epub 2024 Apr 23. J Inorg Biochem. 2024. PMID: 38677004

7

Mitochondria-Targeting Metallodrugs for Cancer Therapy: Perspectives from Cell Death Modes.

Li HM, Wang MM, Su Y, Fang HB, Su Z. Li HM, et al. Among authors: fang hb. ChemMedChem. 2024 Aug 1;19(15):e202400120. doi: 10.1002/cmdc.202400120. Epub 2024 Jun 14. ChemMedChem. 2024. PMID: 38696276 Review.

8

Molecular probes for super-resolution imaging of drug dynamics.

Fang H, Wang M, Wei P, Liu Q, Su Y, Liu H, Chen Y, Su Z, He W. Fang H, et al. Adv Drug Deliv Rev. 2024 Jul;210:115330. doi: 10.1016/j.addr.2024.115330. Epub 2024 May 10. Adv Drug Deliv Rev. 2024. PMID: 38735627 Review.

9

Light switchable Ir(III)-based photosensitizers: a dual-state system for non-invasive, reversible ROS control in tumor therapy.

Chu Z, Xu N, Su Y, Fang H, Su Z. Chu Z, et al. Dalton Trans. 2024 Nov 26;53(46):18585-18591. doi: 10.1039/d4dt02673j. Dalton Trans. 2024. PMID: 39470257

10

An artesunate-modified half-sandwich iridium(iii) complex inhibits colon cancer cell proliferation and metastasis through the STAT3 pathway.

Deng D, Xu N, Wang M, Zhang G, Su Y, Fang H, Su Z. Deng D, et al. RSC Chem Biol. 2024 Dec 17. doi: 10.1039/d4cb00114a. Online ahead of print. RSC Chem Biol. 2024. PMID: 39697768 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters